Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Digi-Tech Pharma & AI 2025" conference has been added to ResearchAndMarkets.com's offering. In this 8th edition as we explore the novel technologies and ...

A US listing for the oncology specialist continues a bumper year for biotech IPOs.

The tie-up marks the latest pharma company to enlist the AI-powered drug discovery services of Generate.

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage biotechnology company developing next-generation targeted radiopharmaceuticals, today announced that Pharma Tech Outlook has named MTTI ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...

Royston, GA – Pharma Tech Industries, a leading global provider of contract manufacturing and packaging solutions for pharmaceutical, medical device, and wellness products, has announced the immediate ...

In a bid to associate themselves with the vanguard of professional practice, marketers are ever-eager to embrace new technologies, though in highly regulated sectors, the shock of the new has a little ...